Studies on Adsorption International Learning Initiative Global

This study is testing a blood-filtering (adsorption) therapy during dialysis to remove inflammation-causing proteins like interleukin-6 (IL-6) and C-reactive protein (CRP) from people with kidney failure on hemodialysis, to see if it reduces inflammation and improves their health. **You may be eligible if...** - You are 18 years or older - You are receiving standard hemodialysis three times a week (at least 4 hours per session) for kidney failure - Your dialysis is considered adequate (KT/V ≥ 1.4) - You have elevated inflammatory markers (IL-6 or CRP) - You do not have an active infection or inflammatory flare-up at enrollment **You may NOT be eligible if...** - You have an active infection or ongoing inflammatory condition - You are not on a standard hemodialysis schedule - You are pregnant or have other conditions making participation unsafe Talk to your doctor to see if this trial is right for you.